Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services... see more

TSX:WELL - Post Discussion

View:
Post by retiredcf on Aug 26, 2024 6:50am

Hang In There

I've owned these for quite a while (KXS 5 yrs; WELL 4 yrs; CTS 3 yrs) but they haven't performed as I'd hoped (KXS +17%; WELL +4%; CTS -1%). Note that I've added to each since the initial purchase. I understand 'wait time' and that the market sometimes takes a while to respond to fundamentals, but I feel I've given these all a fair chance and yet I continue to believe - and to hold! Can you offer me any assurances to either continue holding or selling any of the three stocks?

KXS has been a disappointment but we do believe its time will come. It has too much cash and we wish it would spend some. It does not help recent buyers, but we would note it is at least up more than 10X from its 2014 IPO. Close to 50% EPS growth is predicted for 2025 and we think it is worth holding to see if that can be delivered. 

WELL is executing well, but not getting the valuation we think it deserves. It may do an asset sale to provide more funds for M&A deals. It is much smaller, but we do believe in management here. 

CTS struggled with two things in the past: debt and earnings growth. But we think both have been largely resolved. Since 2022 debt is lower by more than $100M, and EPS of 31c in 2022 should rise to 62c next year. Based on all metrics it is very cheap, and with lower debt and better growth its valuation multiple certainly has the potential to increase. (5iResearch)
Comment by retiredcf on Aug 26, 2024 7:20am
More details from a question later in the week. GLTA On the last quarter conference call there was a review of the earnings and potential growth in earnings per share in the future. With the organic growth and potential margin improvement from cost cutting, earnout payments dropping in future years, spin out of Provider Solutions and the potential monetization of Circle/Wisp (assuming the money ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities